Burning Rock Biotech (BNR) Non-Current Receivables (2022 - 2023)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Burning Rock Biotech has reported Non-Current Receivables over the past 2 years, most recently at $738880.9 for Q4 2023.

• Quarterly results put Non-Current Receivables at $738880.9 for Q4 2023, up 2.94% from a year ago — trailing twelve months through Dec 2023 was $738880.9 (up 2.94% YoY), and the annual figure for FY2023 was $749000.0, down 1.49%.
• Non-Current Receivables for Q4 2023 was $738880.9 at Burning Rock Biotech, up from $717783.8 in the prior quarter.
• Over the last five years, Non-Current Receivables for BNR hit a ceiling of $738880.9 in Q4 2023 and a floor of $717783.8 in Q4 2022.

Peer Comparison